secwatch.observer — SEC 8-K summary
======================================

Issuer:     CareDx, Inc. (CDNA)
CIK:        0001217234
Form:       8-K
Filed at:   2024-01-09T23:59:59+00:00
Accession:  0001193125-24-004834
Event type: earnings
Sentiment:  positive
Materiality: 0.70
Item codes: 2.02, 9.01, 7.01
LLM model:  deepseek-v4-flash:cloud@v2

CareDx prelim FY2023 revenue $279-280M, above high end of guidance; Q4 patient volumes up 4% QoQ
--------------------------------------------------------------------------------

- Full-year revenue expected $279-280M, exceeding $277M high-end guidance; FY2022 was $321.8M.
- Q4 testing-services revenue $46-47M vs $47.8M in Q3; patient results ~39,900, up 4% sequentially.
- Patient & Digital Solutions FY rev ~$37M (+29% YoY); Products ~$33.5M (+14% YoY).
- Repurchased 2.8M shares for $26M; cash & equivalents $235M with no debt.
- Fifth consecutive quarter of testing-services collections above 100% of revenue.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1217234/000119312524004834/0001193125-24-004834-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1217234/000119312524004834/d93749d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-004834

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer